This project will support the automation of the firm’s clinically validated, TRL-8 next generation sequencing-based pathogenomic assay for the detection of infectious disease on two different platform...
FUSION GENOMICS CORP.
14 enregistrements totalisant 3,401,099.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $2,954,131 | 13 enregistrements |
| Diversification de l'économie de l'Ouest Canada | $446,968 | 1 enregistrement |
Enregistrements
Fusion’s current assay has a 24-hour turnaround time and a complex workflow that requires high technical knowledge. The company has identified several avenues to simplify the workflow and bring the tu...
Support for Fusion Genomics to continue operations during the COVID-19 pandemic
This project will support the R&D required to reduce the time from sample to result of the firm’s next generation sequencing-based test for diagnosing human pathogens from the current 12 hours to 8 ho...
The purpose of this project is to provide employment and work experience in a business associate role for a life sciences graduate in a company that develops and produces diagnostic test kits based on...
This project will create a centralized, comprehensive and curated database for known viral genomes and pan-viral identification tools and related bioinformatics.These resources will be made commercial...
Fusion Genomics plans to introduce its ONETest Pathogenome, which will diagnose all known human pathogens, to the United Kingdom with the objective to close 1-2 pilot projects with KOL hospitals.